Page 60 - Inaugural Lecture Prof Dr Ahmad Sobri Muda

Neurointervention

With the collaborative efforts of interventional neuroradiologists
and stroke neurologists, five major randomised trials were published
in leading medical journals around mid 2010’s. Main emphasis
pertaining the clinical contribution of mechanical thrombectomy
in the treatment of ischemic stroke, highlighting that mechanical
thrombectomy is more effective than the conventional treatment
when performed in centres with substantial experience. These
trials’ optimistic results were widely accepted, expanding the
boundaries of neurointerventional practise even farther. Many
guidelines published by major Western and Asian societies of
stroke neurologists and interventional neuroradiologists swiftly
incorporated mechanical thrombectomy as an important treatment
option for acute stroke, particularly with large artery occlusion.
Many leading medical imaging companies and leading medical
device companies have started to pay more attention to endovascular
procedures related to acute stroke and intracranial arteriosclerotic
disease.
There are many new stroke thrombectomy devices undergoing
trials and development. In recent years, there have been numerous
new stent retrievers coming to the market, and in the last 2 years
alone, at least 10 new stroke devices, from aspiration catheters,
stent retrievers and access catheters, approved by device authorities.
Medical imaging is also rapidly developing in areas related to
neurointervention, such as stroke. New angiographic imaging
algorithms like CBCT (VasoCT; Philips) developed to visualise
better vessels beyond occlusion to assist neurointerventionist
navigate safely and effectively. The resultant image with more
detailed 3D acquisition helps neurointervention to better understand
the working projections and the lesion, making the endovascular
treatment more effective. (Tom D. Potter et. al 2022).

❚❘❘ 50